News
Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
Posted on 14 May
WHO publishes dementia risk reduction guidelines
The World Health Organisation (WHO) has today (Tuesday 14 May) published a report containing updated guidance on the latest evidence around dementia risk reduction. While the report highlights several risk factors that require further research to strengthen the evidence base, it strongly recommends not smoking, physical exercise, controlling blood pressure and managing diabetes as ways […]
Posted on 24 Apr
The mobile game that can detect Alzheimer’s risk
A specially designed mobile phone game can detect people at risk of Alzheimer’s – according to new research from the University of East Anglia. Researchers studied gaming data from an app called Sea Hero Quest, which has been downloaded and played by more than 4.3 million people worldwide. The game, created by Deutsche Telekom in […]
Posted on 16 Apr
£20m Research and Technology Centre to enable people with dementia to live in own homes for longer
A ground-breaking £20m research centre will develop new technologies to create dementia-friendly ‘Healthy Homes’ and provide insights into how dementia develops. The new Care Research & Technology Centre at Imperial College London joins six national discovery science centres that collectively make up the UK Dementia Research Institute (UK DRI). This unique new centre will use […]
Posted on 10 Apr
Dunfermline woman steps up to support dementia research in memory of dad
A midwife is taking on the Glasgow Kiltwalk to raise money for dementia research in honour of her father who died with early-onset Alzheimer’s disease. Claire Massey, from Crombie, Dunfermline, will walk 15 miles on Sunday 28 April to raise money for Alzheimer’s Research UK. The 38-year-old mum-of-two is supporting the UK’s leading dementia research […]
Posted on 09 Apr
Non-invasive brain stimulation may help memory and thinking skills
Nature Neuroscience: Working memory revived in older adults by synchronizing rhythmic brain circuits New US research has shown that a non-invasive brain stimulation procedure could help improve memory and thinking in older adults. The findings are published today (Monday 8 April) in the journal, Nature Neuroscience. Dr Sara Imarisio, Head of Research from Alzheimer’s […]
Posted on 04 Apr
Cambridge researchers sweep the board at leading dementia conference
Alzheimer’s Research UK’s Research Conference 2019 Dr Jason Sang wins £2,000 Jean Corsan prize for best paper by an early career researcher Dr Jemeen Sreedharan gets £25,000 research award for Early Career Investigator of the Year Dr Ben Falcon takes share in Rising Star Award with £10,000 for research expenses Dr Thomas Cope also shares […]
Posted on 27 Mar
A shorter reproductive window in women linked to increased dementia risk
A shorter reproductive window in women linked to increased dementia risk Neurology: Reproductive period and risk of dementia in a diverse cohort of health care members A team of US-based researchers has found that a shorter reproductive window is associated with a higher dementia risk. They also found a higher risk of dementia in women […]
Posted on 27 Mar
Existing drug reduces brain shrinkage in mice with Alzheimer’s features
Science translation medicine: A farnesyltransferase inhibitor activates lysozyme and reduces tau pathology in mice with tauopathy A team of US researchers have found that a drug, lonafarnib, is able to decrease brain shrinkage and reduce the build-up of tau in mice. The findings are published today (Wednesday 27 March) in the journal, Science Translation Medicine. […]
Posted on 25 Mar
Reduced number of new brain nerve cells linked to Alzheimer’s
Nature Medicine: Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease An international team of researchers have pinpointed early brain changes that suggest if someone will develop Alzheimer’s disease. The findings are published today (Monday 25 March) in the journal, Nature Medicine. Dr Rosa Sancho, Head of […]
Posted on 21 Mar
Phase III aducanumab trials for Alzheimer’s disease stopped early
Pharmaceutical companies Biogen and Eisai today (Thursday 21 March) announced they are to discontinue two phase III trials of the Alzheimer’s drug aducanumab. The ENGAGE and EMERGE trials were designed to evaluate the efficacy and safety of aducanumab in people with a confirmed diagnosis of mild cognitive impairment (MCI) or mild Alzheimer’s disease. Aducanumab is […]